Answers are grounded in this paper and cite their sources.
Sir: In the field of scar management, including its prevention and treatment, the number of clinical trials using new drugs and devices has increased considerably, as evidenced by recent publications in Plastic and Reconstructive Surgery.1,2 In this Letter, I would like to draw attention to the link between high blood pressure (hypertension) and scar quality and appearance, which could have a considerable impact on future clinical trials. In light of this, I would like to propose that screening for hypertension should be an integral part of clinical trials for keloid and scar treatments. In our hospital, where cases of keloid and hypertrophic scar have been treated over an extended period, we have observed that severe keloids are often associated with high blood pressure (hypertension). Indeed, an analysis of 100 keloid patients in 20113 revealed that patients with multiple (more than three) or large keloids (>10 cm2) had higher blood pressure than patients with mild keloids (fewer than two or <10 cm2). For example, in one case, keloid symptoms were alleviated when antihypertensive drugs were administered.4 Although an analysis of the link between hypertension and keloids is ongoing, the results so far suggest that hypertension is an important risk factor for the aggravation of keloids and scars. The generation of heavy scars, including keloid and hypertrophic scars, is associated with multiple factors. These include local factors (e.g., tension), genetic factors (e.g., single nucleotide polymorphisms), and systemic factors (e.g., hypertension). Hypertension is one of the risk factors for heavy scars. I would like to draw attention to the following points: The main cause of keloids and heavy scars is unlikely to be hypertension, because one-fourth of adults suffer from hypertension, but most do not develop keloids. However, we observed that keloid or hypertrophic scar formation was higher after invasive surgery in patients with hypertension than in similar patients with normal blood pressure. Actually, many elderly patients developed keloids for the first time after undergoing such surgery (Fig. 1). This suggests that such patients are different from patients who acquired keloids earlier in life. By itself, treatment for high blood pressure cannot cure heavy scars, but symptoms of scars may be improved by such treatment. Moreover, treatment for high blood pressure may prevent the formation of heavy scars. People of African American or African origin have significantly higher rates of hypertension than Caucasian people5; this may be related to the fact that the former have higher rates of keloids. Heavy scars and hypertension may have a common pathologic condition, but this should be verified in the future. I would recommend that the blood pressure of patients with heavy scars be checked, and that hypertensive patients be excluded from clinical trials of new drugs and devices for the prevention and treatment of scars. Recently, a clinical trial for transforming growth factor-β31,2 was stopped in phase III. Such results may be changed if the blood pressure of the participants is tested before the clinical trial is commenced.Fig. 1: A keloid case associated with hypertension. The patient was a 66-year-old man with hypertension. He had no keloids before the age of 60 but developed keloids after surgery. Patients who do not have a strong genetic disposition for keloid formation, but who experience hypertension, may be more susceptible to severe scars.DISCLOSURE The author has no financial interest to declare in relation to the content of this communication. Rei Ogawa, M.D., Ph.D. Department of Plastic, Reconstructive, and Aesthetic Surgery Nippon Medical School 1-1-5 Sendagi Bunkyo-ku Tokyo 113-8603, Japan [email protected]
No takes yet. Share an insight, caveat, or question.
Rei Ogawa (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: